Clinical Trials Browser

Phase 1 × Rivaroxaban × Gastrointestinal × Clear all

NCT06065592 2023-10-06

CAT_PB

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Carcinoma, Hepatocellular, Immune System Diseases, Inflammation, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Thromboembolism, Thrombosis